TAMPA, Fla., May 15, 2023 /PRNewswire/ -- As the need for more advanced technology continues to grow, TGH Imaging is increasing patient access across four counties for breast cancer screening by adding Genius™ 3D Mammography™ exams made by Hologic to 18 locations in Hillsborough, Pasco, Pinellas and Palm Beach counties. Also called tomosynthesis, 3D mammography is a form of mammography that creates a 3D image of the breast that can better detect breast cancer.

"3D mammography has become the superior choice in breast imaging," said Dr. JoAnn Gierbolini, a Women's subspecialized radiologist at TGH Imaging and collaborative assistant professor at the USF Morsani College of Medicine. "Being able to utilize this technology daily across four counties will allow our team to detect breast cancers earlier but also provide access for so many more women in our area," she said. Compared with 2D mammography alone, 3D mammography can find 20 to 65% more invasive breast cancers.2

With breast tomosynthesis technology, the Hologic system creates a 3-dimensional image of the breast structure, which enables radiologists to more clearly see through overlapping tissue to detect cancers, often at an earlier stage.

A 3D mammogram can be done in conjunction with a synthesized 2D mammogram and does not require additional exam time or compression. Used as both a screening and diagnostic tool, a 3D mammogram is analyzed by a TGH Imaging dedicated women's subspecialized radiologist with the assistance of a Computer Aided Detection (CAD) System.

"3D Mammography is the standard of care in breast imaging, and we're thrilled to expand this service further throughout TGH Imaging," says Sherri Lewman, SVP of Enterprise Imaging at Tampa General Hospital. "We want to offer the best technology available for early cancer detection for all of our patients and providers across all of our locations, coast to coast."

To schedule any imaging appointment at TGH Imaging, call (813) 874-3177 or visit https://www.tghimaging.com/appointment-request/.

1) FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005 2) Results from Friedewald, SM, et al. "Breast cancer screening using tomosynthesis in combination with digital mammography." JAMA 311.24 (2014): 2499 2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions ® on screening outcomes. Individual results may vary. The study found an average 41% (95% CI: 20-65%) increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only.3) Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736. 4) Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63. 5) Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 6) McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43. 7) Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr26;315(16):1784-6

Women's Health Homepage